Influcid

Medicinal product

(Invented) name

Influcid

Active substance (s)

Aconitum trit. D3/Gelsemium trit. D3/Ipecacuanha trit. D3/Phosphorus trit. D5/Bryonia D2/Eupatorium perfoliatum trit. D1

Strength

25 mg/25 mg/25 mg/25 mg/25 mg/25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

Alpen Pharma GmbH, Vokietija

Date of authorisation

1997-09-03

Date of renewal

2013-11-14

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

16.2

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Aconitum trit. D3	25 mg
Gelsemium trit. D3	25 mg
Ipecacuanha trit. D3	25 mg
Phosphorus trit. D5	25 mg
Bryonia D2	25 mg
Eupatorium perfoliatum trit. D1	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
54914	68940	1068940	lizdinė plokštelė	N40		Nereceptinis	LT/1/97/3438/002	Tiekiama	-	-	No	-	-	Download
5670	10895	1010895	lizdinė plokštelė	N60		Nereceptinis	LT/1/97/3438/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2013-11-14	Perregistruotas
1997-09-03	Registruotas